NORPRAMIN- desipramine hydrochloride tablet, sugar coated 
Validus Pharmaceuticals LLC


Medication Guide
Norpramin® (desipramine hydrochloride tablets USP)

Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

Read the Medication Guide that comes with your or your family member’s, antidepressant medicine.  This Medication Guide is only about the risk of suicidal thoughts and actions with antidepressant medicines.  Talk to your or your family member’s, healthcare provider about:

What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?

1.  Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment.

2.  Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions.  Some people may have a particularly high risk of having suicidal thoughts or actions.  These include people who have (or have a family history of) bipolar illness (also called manic-depressive illness) or suicidal thoughts or actions.

3.  How can I watch for and try to prevent suicidal thoughts and actions in myself or a      family member?

Who should not take NORPRAMIN?

Call a healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:

Visual Problems

What else do I need to know about antidepressant medicines?

Call your doctor for medical advice about side effects.  You may report side effects to FDA at 1-800-FDA-1088.

You may also report side effects to Validus Pharmaceuticals LLC U.S. at 1-866-982-5438 (1-866-9VALIDUS). 

This Medication Guide has been approved by the U.S. Food and Drug Administration. 

Manufactured for and Distributed by:

Validus Pharmaceuticals LLC
119 Cherry Hill Road, Suite 310
Parsippany, NJ 07054
1-866-982-5438 (1-866-9VALIDUS)

Product of Finland

© 2018 Validus Pharmaceuticals LLC

60040-02                         November 2018

Revised: 12/2023
Validus Pharmaceuticals LLC